Relationship Between Glucose Fluctuations and ST-Segment Resolution in Patients With ST-Elevation Acute Myocardial Infarction
Keiichi Tsuchida1, Norihito Nakamura1, Satoshi Soda2
1Department of Cardiology, Niigata City General Hospital.
Insights
Glucose fluctuations, measured by MAGE and AUCMBG, are linked to poor reperfusion in ST-elevation myocardial infarction (STEMI) patients. High MAGE levels predict suboptimal ST-segment resolution after primary PCI, suggesting a therapeutic target.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- ST-elevation myocardial infarction (STEMI) requires timely reperfusion therapy.
- Myocardial reperfusion injury can be assessed using electrocardiographic surrogate markers.
- Glucose metabolism and its fluctuations may influence myocardial reperfusion outcomes.
Purpose of the Study:
- To investigate the relationship between glucose fluctuations and reperfusion injury markers in STEMI patients.
- To determine if glucose fluctuation parameters predict suboptimal ST-segment resolution (STR) after primary percutaneous coronary intervention (PCI).
Main Methods:
- Prospective study of 63 STEMI patients undergoing primary PCI.
- Continuous glucose monitoring to assess mean amplitude of glucose excursion (MAGE) and area under curve with reference to mean blood glucose (AUCMBG).
- Electrocardiograms 60 minutes post-PCI to measure ST-segment resolution (STR).
Main Results:
- MAGE and AUCMBG were significantly higher in patients with suboptimal STR (< 30%).
- Univariate analysis revealed MAGE ≥ 70 mg/dL and AUCMBG ≥ 20 mg/dL/day were associated with suboptimal STR.
- Multiple logistic regression identified MAGE ≥ 70 mg/dL as an independent predictor of suboptimal STR (OR = 22.5).
Conclusions:
- Glucose fluctuations correlate with electrocardiographic markers of impaired myocardial salvage in STEMI post-reperfusion.
- Elevated MAGE is a significant predictor of suboptimal reperfusion.
- Glucose fluctuations may represent a modifiable therapeutic target to mitigate myocardial reperfusion injury in STEMI.
Abstract:
This study was conducted to assess whether any relationships exist between glucose fluctuations and electrocardiographic surrogate markers of reperfusion injury in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).We prospectively studied 63 consecutive patients with STEMI undergoing primary PCI. Patients had either diabetes (n = 30), impaired glucose tolerance (n = 26), impaired fasting glucose (n = 1), or normal glucose tolerance (n = 6). STsegment resolution (STR, %) was measured using electrocardiograms recorded 60 minutes after PCI. STR was categorized as ≥ 30% and < 30%. Glucose fluctuations were assessed by the following parameters obtained from a continuous glucose monitoring system: mean amplitude of glucose excursion (MAGE, mg/dL); and area under curve with reference to mean blood glucose (AUCMBG, mg/ dL/day).Both MAGE and AUCMBG were significantly higher in STR < 30%. In univariate analysis, MAGE ≥ 70 mg/dL (OR = 17.0; 95%CI, 1.93-150.12; P < 0.01), AUCMBG ≥ 20 mg/dL/day (OR = 10.9; 95%CI, 1.92-61.77; P < 0.01), and reperfusion arrhythmias (OR = 7.6; 95%CI, 1.32-44.29; P < 0.05) were significantly associated with suboptimal STR. Multiple logistic regression analysis showed only MAGE ≥ 70 mg/dL was predictive of suboptimal STR (OR = 22.5; 95%CI, 2.43-208.66, P < 0.01).Parameters of glucose fluctuations correlated with electrocardiographic surrogate markers of impaired myocardial salvage in STEMI after reperfusion therapy. Our results suggest that glucose fluctuations may represent a potential therapeutic target to reduce myocardial reperfusion injury in STEMI.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome IV: Interprofessional Care


